HyperAcute Melanoma Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HyperAcute Melanoma Vaccine, covering 2011-01-13 to 2011-01-13. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma [Phase 2]